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Abstract:
Objective:  To examine parents’ and health professionals’ views on 
informed choice in newborn blood spot screening, and assess information 
and communication needs.
Design and participants:  A qualitative study involving semi-structured 
telephone interviews and focus groups with 47 parents of children who were 
either found to be affected or unaffected by the screened conditions, and 35 
health professionals with differing roles in newborn blood spot screening 
programmes across the UK. 
Results and conclusions:  Parents and health professionals recognise a 
tension between informed choice in newborn blood spot screening and 
public health screening for children.  Some propose resolving this tension 
with more information and better communication, and some with rigorous 
dissent procedures.  This paper argues that neither extensive parent 
information, nor a signed dissent model adequately address this tension. 
Instead, clear, brief and accurate parent information and effective 
communication between health professionals and parents, that take into 
account parents’ information needs, are required, if informed choice and 
public health screening for children are to co-exist successfully.
Key words:  newborn screening, informed choice, consent, dissent, parents, 
health professionals.
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Introduction:
Since the introduction of blood spot screening of all newborns for 
phenylketonuria (PKU) and congenital hypothyroidism (CHT) in the UK, in 
the 1960s and 1980s respectively, consent for screening has generally been 
assumed or implied.  Usually, midwives looking after mothers and babies in 
their own homes during early postnatal visits, would gently forewarn 
mothers of the ‘heel-prick’ to collect a little of their babies’ blood, 
portraying it as routine and no cause for concern. This was primarily 
because screening for PKU and CHT was known to be highly effective in 
preventing severe disability. More recently, however, this practice has been 
challenged by raised expectations for informed consent for treatment, 
screening, diagnosis and research. 1;2 Informed choice has been defined 
differently by a variety of stakeholders.  Some refer to ‘choice’, others to 
‘consent’ or ‘dissent’: our interpretation appears in box 1. Promoting 
informed choice has increased awareness of the need to communicate 
clearly with parents about: their babies’ health; available tests and the 
potential consequences; and the choices they face.  This is reflected in the 
growing research literature about communication for screening (see Special 
Issue, Health Expectations, 2001)15  and in the reports of the UK National 
Screening Committee. The first report in 1998 addresses choices in light of 
screening results: treatment choices, lifestyle choices and choices about 
further tests.3 In comparison, the second report in 2002 promotes informed 
choice for screening, and calls for 1) screening to be offered to individuals 
who are helped to make an informed choice about it, and 2) screening to be 
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seen as a programme to assist in the early identification of diseases and not 
a guarantee of diagnosis or cure.4  This has led to the proliferation of written 
information for parents, some of which addresses the benefits and possible 
harms of screening so that parents can make an informed choice about 
whether or not their baby should be screened.5 
[Place box 1 about here]
Demands for choice, however, are in tension with concerns about child 
health and current newborn screening practice.6 Questions arise about 
whether choice will lead to reduced uptake in screening;7  what information 
people need and its effects on their decision-making;8 and whether informed 
choice is appropriate for all screening programmes.7 A parent refusing 
newborn screening for a very low prevalence condition with an unproven 
intervention would be more justified in making such a refusal than a parent 
refusing screening for a high prevalence, catastrophic condition which is 
easily preventable 5;9 Newborn blood spot screening presents a range of 
scenarios between these two extremes (see box 2), thereby raising tensions 
between parental autonomy and preventive public health strategies.  
[Place box 2 about here]
The UK Newborn Screening Programme Centre was commissioned in 2002 
to set national standards for newborn blood spot screening; to develop 
policies and procedures for process standards, clinical consent, blood 
sampling, clinical referral, registration of affected cases, and storage and use 
of residual blood spots; and to develop parent information and 
communication guidelines and training for health professionals. 
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In order to develop these information and communication resources, we, the 
Parent Support Research Team of the Programme Centre, sought the views 
of parents and health professionals about their information and 
communication needs.  Their views have informed the UK Newborn 
Screening Programme Centre’s development of information resources for 
parents and health professionals;10 and standardised referral pathways for 
babies thought to be affected by screened conditions.11This paper reports the 
findings that relate specifically to informed choice.  
Methods
Sampling
Parents were purposively recruited for their diverse experiences of screening 
and the conditions, and socio-demographic status. Parents of unaffected 
children were sought through statutory services (a suburban GP surgery, an 
inner city statutory parent support group and a market town factory). 
Parents of children found to be affected by the conditions were accessed 
through condition-specific support organisations. Most parents had a child 
under three years old, and many of these had babies under one year old. 
Two parents attending one focus group had young adult children.  Overall 
the ages of the children born to parents ranged from 6 weeks to 23 years. 
Health professionals were recruited through professional and service 
organisations, screening training events and a charity.  
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Interviews and focus groups
Telephone interviews and focus groups with 47 parents (42 mothers and 5 
fathers) and 35 health professionals were carried out between July and 
October 2003 (see table 1). 
[Insert table 1 about here]
Recruitment
Participation in the research was voluntary, anonymous and confidential. 
Study information was distributed through contacts in health service and 
parent organisations, or sent directly to parents who responded to 
advertisements placed in condition-specific support organisation 
newsletters. Those who wished to participate were first asked to complete, 
sign and submit two consent forms, which were then signed by a researcher 
and one returned to the participant.  
Data collection and Analysis
Semi-structured interview guides were developed for the different 
categories of parents.  Topics included:  experience of the heel-prick test 
and the screening process overall including receiving results; the timing and 
format of information they received about the test; who provided the 
information; what, in retrospect, they would have liked to have known 
before the test; and issues related to informed choice and consent.  In focus 
groups, parents were shown copies of leaflets about newborn screening, and 
asked for feedback on the information provided.  Health professionals were 
asked about their role in the newborn blood spot programme, particularly in 
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communicating with parents and delivering results, use of and access to 
useful information resources, views on informed choice and consent, issues 
and challenges in communicating with parents about newborn screening, 
and training needs.  
The guides were piloted in initial focus groups and interviews and adapted 
to capture both the similar and divergent issues across the different 
categories of interviewee.  All interviews and focus groups were tape-
recorded and transcribed.  Two researchers analysed each transcript, 
identified themes, coded the transcripts and compared similarities and 
differences until data saturation was achieved.  
Results
Analysis of the data revealed debates about a spectrum of circumstances 
relating to the degree of parental choice and methods for recording parents’ 
decisions (see Figure 1).  This spectrum ranges from no parental choice 
(mandatory screening) through routine screening, where opt out is possible 
although not encouraged, to full parental choice, where parents are given 
information about the benefits and limitations of screening and asked to 
choose whether or not to have their baby screened for any or all of the 
conditions.  Different amounts of information, and different methods of 
communication, were described for supporting different positions along the 
spectrum.  Minimal one-way oral communication, with midwives advising 
parents of how their baby will be screened and for what, was associated 
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with routine screening. A need for more complete information, and better 
communication supported by written materials, was anticipated as parental 
choice and parental responsibility are increased. The following sections 
summarise the findings that illustrate each of the continua described above 
and in Figure 1. 
Insert figure 1 about here
Information for parents
Most parents recalled being minimally informed about newborn blood spot 
screening before the test, whether or not their babies were affected.    
I can’t remember anything being discussed with either of mine and told that it was  
actually done [Unaffected mother].
I don’t recall being given very much information….I think [all]I knew about the  
heel prick test was that they check up for PKU. I had no idea that there was any  
genetic component to the testing  [CF father].
Even with minimal information, most parents reported that they were happy 
to accept what they perceived as routine screening recommended by their 
midwife and the health service.  Focusing on other priorities postnatally, 
parents paid little attention to the test and were unfamiliar with the 
conditions being screened.  A mother said:
All I really remember about that was being told that if anything comes up positive,  
it can be treated easily.  I can’t remember [anything about the conditions]. … it’s  
only 6 days after the birth, your head is all over the place, so I took very little  
notice of it.   I hadn’t had much sleep either. So I probably didn’t listen to what  
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she was saying if I’m truthful…and I remember actually thinking ‘oh that’ll be  
fine, that’ll be okay’ [CHT mother].
Other parents had received a leaflet as well as information orally from the 
midwife, and had discussed screening with the midwife. 
I was given a leaflet on the day, [and] one earlier on and it was about the PKU 
and the congenital hypothyroidism… they also advised for [the baby] to wear  
some socks so that the feet were nice and warm. There’s quite a good leaflet that  
they give, I’ve got it in front of me…there’s a diagram … there’s like half a page  
on PKU and congenital hypothyroidism [CHT mother]
Several parents, particularly those whose babies were later found to have 
one of the conditions, said they did not recall midwives drawing attention to 
the significance of the tests.  
…even when we were in hospital they were saying ‘you know your midwife will be  
doing the heel prick test between 6 and 14 days’ …..  And then the midwife comes  
and says ‘right I’m going to do the test today and I’ll prick the heel and bla, bla,  
bla’ [but]… you’ve got no idea of the seriousness of it really.  That’s what it boils  
down to [PKU mother].
Most parents of unaffected children heard nothing more after the blood 
sample was taken having been told that ‘no news is good news’. 
I knew something was going to happen because of the pre-baby lessons you go to.  
That wasn’t very informative.  They just said they’d do this test.  They never said  
why it was being taken…what information you’d get. And then when the baby was  
tested you just got absolutely nothing, nothing at all [Unaffected mother].
With hindsight, most parents see no need for detailed information about the 
screening tests or the conditions tested for before, or at the time of, the test.  
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You need to know basics really…I think it’s good to know what the test is and that  
you’re going to have it, remind us when you’re going to do it, then…once the  
results are in, if it was positive then I would want to know more about it.  I  
wouldn’t want to know before because I'd be worried about the results  
[Unaffected mother].
I think you can be overloaded with information, and I think other than making the  
judgement that it’s accepted practice to do it I think I'd be quite happy to go along  
with that…I don’t really feel that I wanted detail of what exactly what tests were  
done or anything [CF father].
Prior, basic knowledge about the conditions and their implications was 
regarded as most significant when babies were found to have the conditions. 
Having got the letter back saying it’s fine, I’m not so bothered about the written  
information, but if there was a problem I’d be furious if I hadn’t known earlier  
about the conditions [Unaffected mother].
You need to know from the beginning…what these initials stand for… I didn’t  
know what PKU was… I didn’t know what the consequences were.  It would have  
been nice to know why the baby was having the heel prick and what these initials  
stood for [PKU mother].
 
Degree of Parental Choice
Most parents did not experience newborn screening as something they could 
choose or refuse on behalf of their baby; most perceived it as a routine test.  
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I’m very much in favour of [screening] being done…but on the other hand,  
parents do feel… around the postnatal period you do feel pretty pushed about and  
trampled over…er…anything that seems to give parents a wee bit more respect  
then… I don’t think people are all that disrespectful, just that they’ve got other  
priorities [CF father].
If they had been offered a choice, many said they would have opted for their 
child to be screened. 
I just assumed it must be important to do it.  So, I just thought that’s fine.  If it’d  
been an injection I suppose you’d give it more thought.  If it’s a screening thing  
then that can only be good can’t it? [Unaffected parent]
The strength of feeling favouring screening was strongest amongst parents 
of affected babies, most of whom considered that screening should be 
compulsory or at least routine. 
I personally don’t think [parents should be given a choice], because it’s so  
important from the child’s point of view, that if conditions are identified and  
managed for the benefit of the child er… I’m looking at it totally from the child’s  
point of view [CF mother].
I don’t see that you could have a choice really to be honest, because with  
something like the PKU, if they don’t get it straight away…we were told by the  
time he was 6 months old, had he not had the test, that he would have been  
physically and mentally handicapped.  So really I don’t think that consent would  
be the right thing [PKU mother].
Some health professionals also thought that screening should not be a matter 
of ‘choice’ because of the importance of early detection of serious 
conditions (particularly PKU and CHT).
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For the four things that are being tested, I would say definitely they need to have  
information.  I’m not sure whether the element choice should be there… I think it  
should be something that is standard…particularly like for the PKU, because you  
know early treatment can mean lots of difference [Sickle Cell Nurse].
That’s a very hard question because I think that you would actually be heading in  
to Child Protection territory if they refused. Because the person who would suffer  
for the rest of their days would actually be the child [GP].  
Whilst some health professionals indicated that parents should have a choice 
about screening, most expressed the view that there should be a strong 
expectation that babies should be screened: 
It is such a tragedy if phenylketonuria is missed, and I think the same could apply  
to hypothyroidism.  And I think that the parents should be told ‘Really this test  
needs to be done.’  …But obviously they do have a choice. They can refuse. Cystic  
fibrosis, well it’s been the whole problem, hasn’t it? Because cystic fibrosis is  
usually detected within the first year of life anyway, the evidence that treatment  
actually makes a difference is small.  They do need choice obviously.  I am quite  
happy with our arrangement in Wales, which is that it is an opt-out choice rather  
than an opt-in choice.  Because it is a treatable condition and that seems  
reasonable to me [Paediatrician].  
Some parents and health professionals who favoured informed choice, 
emphasised that if parents were well-informed they would be less likely to 
decline screening, and that systems should be in place to minimise the 
possibility of refusals.
I do [support informed choice] in principle, but then I think if you end up missing  
a child that has a condition and the parents have refused…at the end of the day, I  
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don’t think you should take away parents’ choice…but I think like most things, if  
it’s explained correctly then most parents will agree.  I think it’s when parents  
don’t understand that they’re more likely [to refuse] [Health visitor].
I think most people would accept it as a routine test as long as they’ve been given  
the information, and then if someone really refused then I think it’s important that  
they sign something and that they’re given all the [information] explained by a  
doctor, someone to explain all the implications of not having the test [PKU 
mother]. 
I’m a paediatrician and I think it comes down to…the child should have rights as  
well in this.  So I do feel that yes, informed choice, but I think … informed  
decisions. I think you have to put the information that this is a test that should be  
done for the child and we’re not saying ‘Do you want it or not?’ to the mum.  I  
mean I think that… if a parent didn’t want it I would want to remonstrate with  
them [Paediatrician]. 
Some parents, particularly those whose babies were unaffected by the 
conditions, said that screening should be offered as a choice.  Others 
supported parental choice but raised the issue of this challenging the 
interests of the child.  
No I think it should be a choice.  Yeah it’s the same thing in immunization, you  
give your consent don’t you…? [Unaffected parent]
I think it should be available as a choice really, with a lot of information available  
to back it up.  If a parent really wants to make a reckless decision that’s going to  
impact on their children’s health then they’ve probably got the right to take it, but  
I’m really not sure…it’s a very difficult one [CF father].
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Some health professionals advocated informed parental choice for 
screening, but expected that most would opt for screening to ensure that 
their baby did not have one of the conditions.
I think they need to know exactly what’s going to be tested for and whether there’s  
bits of it they can opt in and opt out of…I’m sure most mothers will want things  
tested to make certain there’s no problem. But I think if they do opt out, it must be  
very well documented that they have not been tested because medical staff will  
assume that they have been tested on the Guthrie for x, y, and z and will not  
necessarily then investigate for it [CF Nurse].
Whilst most parents said they were unlikely to opt out of screening or parts 
of screening, one parent of an unaffected child did indicate that she might 
choose to opt out of screening for some of the conditions, particularly if 
there was some controversy over the value of screening for that condition.  
Recording parents’ decisions
Many parents said they did not recall giving consent for the heel-prick test.
It wasn’t anything I consented to.  I don’t remember signing or agreeing  
[Unaffected mother].
Others recalled being given information orally by the midwife and giving 
verbal consent.  There was some support for implied or verbal consent from 
parents and some health professionals, mostly from those who believed that 
screening should be routine.  
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…if the mother can’t stand it and has to go out while the grandmother [holds the  
baby], then…they ought to have written consent then, but obviously if it’s you  
actually holding the baby then that’s implied consent anyway, if you’re holding  
the baby’s heel up [CF mother/GP].
I think a verbal discussion really between midwife and mother or mother and  
father to say, ‘we do this test and it’s for so and so, have you any objections to us  
doing it?’ And I think that’s enough really.  I mean you don’t have to give written  
consent to have your inoculations or anything like that, do you? [PKU mother]
Some health professionals preferred a verbal consent model, but believed 
that in the current increasingly litigious climate, written consent might offer 
them greater legal protection.∗  
Well, legally, verbal consent isn’t really satisfactory.  If anything happens, say if  
the baby got an infected foot or the test wasn’t done correctly, you know, verbal  
consent means very little really.  A midwife’s… word against the parent. … Maybe  
they could have just a space there, consent for the test. It might be easier, without  
creating any more paperwork [Health Visitor].  
When asked for feedback on a proposed model of verbal consent and 
written dissent, many health professionals and parents of affected children 
were in favour because it would make it easier for parents to give rather 
than withhold their consent.  
I rather like that idea of verbal consent and written dissent. I mean to some extent  
it’s already happening in the NHS.  Some procedures are requiring written  
consent where they’re actually essential procedures which would be negligent if  
 This view is not supported, however, by Department of Health guidance on Consent, 
which explains that a signature alone does not prove that the person was sufficiently 
informed about the procedure to make an informed choice. 12 
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you didn’t do them…I would be wary of being overly bureaucratic. Enormous  
amounts of things we do are sort of verbal consent or even implied consent.  I  
think paediatrics work on that.  We don’t ask for a consent form at the time we  
take a blood sample [Paediatrician].
Some health professionals, however, argued that consent and dissent should 
be treated in the same way; otherwise it might appear coercive.  They also 
thought a small minority of parents would refuse to sign for dissent.  
So they have to write to opt out, but don’t have to write to opt in?  ….either  
they’re writing a consent or not, I don’t think you should have one rule for in and  
one rule for out. Who are you benefiting by putting that consent down?  Are you  
covering your back or are you throwing it back at them later to say well you  
said…it’s your problem?. I’m quite happy for someone to give their verbal  
consent but then I would write down that they have given their verbal consent…  
whether you actually need for them to put a signature to it I don’t know [Sickle  
cell counsellor].
Other health professionals, particularly midwives, supported the status quo 
of consent/dissent being documented by midwives in the antenatal record as 
part of best professional practice.
It’s giving information first and then asking if women would agree to have this  
done, and documenting it in the woman’s baby’s notes. For all of these things  
apart from general anaesthetic, we don’t actually give out consent forms because  
there are so many things we’re gaining consent for.  So, midwives are giving  
verbal information and getting verbal consent and then documenting that…[and 
would document and report any refusals] [Consultant midwife].
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A significant number of parents, of both unaffected and affected children, 
and health professionals supported written consent, though some of these 
were happy with verbal consent.  These parents argued that signing would 
make screening seem more significant, ensure that adequate information had 
been given, and clarify parental intentions.  
Maybe [written consent] would make people think more of what … what actually  
you were having the test done for. You’d have to look into what the test was  
actually about.  But I was quite happy with the verbal consent [CF mother].
If you have to give written consent, the chances are that you’re reading what  
you’re signing for…and that maybe you’re disseminating information, because  
you’re asking people to sign for it. I’m sure 99% people will sign it but at least it’s  
one way of getting the information to us. Because we weren’t really given  
anything to write or sign…[Unaffected parent].
I would have thought it would probably best to sign for it.  Things can become so  
tenuous, I find, nowadays…everybody needs to be clear about what’s happening  
and make sure that they actually understand what’s happening and a signature  
would probably be a good idea [CHT father]. 
Other parents raised the issue of the need for written consent if blood spots 
are to be stored.
…..if they’re keeping the blood I think we ought to sign [Unaffected parent].
I mean I don’t think anybody would have been too bothered with the verbal  
consent until they found out it’s going to be stored for however long, then they  
sort of think ‘hold on’ [Unaffected parent].
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Some health professionals also preferred both written consent and dissent 
because they believed it would protect them better legally, and provide a 
better record for the future as to whether or not screening had taken place.
[Consent] should be in writing and I also think that if they opt out from anything it  
must be in writing that they have opted out, because we had a situation where a  
child hasn’t been tested for cystic fibrosis, but the parents were under the  
impression that they had been tested… It was a boundary problem …so we had  
been told by the parents that she had been screened and it was negative, when in  
fact she hadn’t been screened and when investigated it was positive [CF nurse].
In summary, parents’ and midwives’ experienced screening that was 
virtually compulsory with little information and assumed consent. They 
supported improved information and communication for parental choice, 
albeit tempered by concerns about children’s health.
Discussion
This research has shown that parents and health professionals recognise a 
tension between informed choice and children’s health in the context of 
newborn blood spot screening.  Some participants propose resolving this 
tension with better information and communication, and some with rigorous 
dissent procedures to mitigate the possibility of refusals. 
Although this study includes the views of a small number of parents and 
health professionals who have had experience of newborn blood spot 
screening, its strength lies in its purposive sampling, which enabled us to 
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elicit the range of views of diverse groups of parents and health 
professionals from a variety of geographic areas in the UK, and with a wide 
range of experiences and roles in newborn screening.  
While every effort was made to include a variety of parents with differing 
perspectives and experiences of screening, and from differing socio-
demographic backgrounds, the participants to some extent were self-
selected in that they responded to advertisements or invitations to participate 
in the study and therefore had some degree of interest in the topic.  The 
context of one-to-one interviewing with parents of affected children and 
focus group discussions primarily with parents of unaffected children may 
cause some discrepancy in the type and depth of information received from 
these parents. Some parents in focus groups, whose children were 
unaffected by any of the conditions, expressed limited views on screening. 
This may be because it is difficult to elicit people’s views on a topic that has 
little impact on their lives, or because their babies, who were with mothers 
in two focus groups, distracted them.  Showing parents of unaffected babies 
copies of leaflets was an effective way of eliciting views from them about 
the type of information they would have liked to have seen in a leaflet on 
newborn screening, but we did not elicit this type of feedback from parents 
in the context of one-to-one telephone interviews.
The findings of this study have been presented to mixed working groups of 
health professionals and parents who have responded favourably to the 
19
content, and drawn on it in the formulation of policies to support informed 
choice for newborn screening.10 
Other research supports our finding that parents generally report receiving 
little information about screening, and are not aware that they have any 
choice.13 This is despite research suggesting that increased knowledge of 
screening, its aims and limitations, can improve parents’ experience of an 
affected result,13as well as false-negative results.14 Little is currently known 
about parents’ views about choice and information. One American study, 
published in 1982, suggests that parents do not want to be offered a choice 
about whether or not to have their baby screened,15 but it is not possible to 
relate this finding to the UK, or to the current day. A systematic review has 
found more recently that knowledge and understanding is often poor before 
and after screening.16 More research is needed into the relationship between 
informed choice, uptake of screening, and quality of the experience: as they 
are perceived by parents and patients; in terms of information required to 
implement such a policy; and the impact on decisions and health. Another 
review is currently underway on interventions for improving understanding 
and minimizing psychological impact of screening17 which may bear 
relevance to this paper, and we await their findings with interest. 
The wider screening literature also raises a possible tension between 
informed choice for screening and the need for detailed high quality 
information to support such a policy. Whilst informed choice is 
acknowledged as important there is uncertainty over what this means, how it 
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might be implemented, and whether it can be evaluated.18 It is 
acknowledged that implementing an informed choice policy takes time and 
costs money.6 Furthermore the role of the health professional is recognised 
as pivotal, with informed choice policies relying on the health professional 
to provide information and offer the choice. Research shows some health 
professionals are reluctant to offer fully informed choice.14 Studies of the 
uptake of antenatal HIV testing, reviewed by Zeuner and colleagues, 
suggest that a woman’s decision is influenced strongly by her midwife.19 
Raffle suggests that a fear of reduced uptake, as well as pressures on time to 
explain the limitations of screening results, leads to one-sided public 
screening information encouraging screening, rather than supporting 
informed choice.6 
In drawing on these findings to inform policy and resources supporting 
informed choice for newborn blood spot screening, we have interpreted 
‘better information and communication’ as succinct, evidence-based oral 
and written, well-communicated parent information about the benefits and 
limitations of screening that takes into account the level of information 
parents want in order to make a decision about having their baby screened. 
Rigorous dissent procedures have been developed that require exploration of 
the reasons for dissent and recording that dissent, but without a parent’s 
signature. In written information and discussion, screening is strongly 
recommended by the NHS, but it is clearly stipulates that parents have a 
choice and may opt out. The research evidence of the influence midwives 
have on parents’ decisions highlights the need for standardised, clear 
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communication guidelines, also developed to assist midwives in addressing 
the tension between parental autonomy, children’s rights and state policy. 
These tensions may become more complicated as more conditions are 
screened for in newborns.  
The empirical research presented in this paper, and the policies and 
resources it has informed, reflect Newson’s theoretical exploration of the 
ethical dilemmas and tensions emerging from the interplay between parental 
autonomy, children’s welfare and state policy.9 Newson argues that whilst 
refusals for newborn screening may be morally unjustified, ultimately 
parents have the right to make such decisions about their child’s welfare 
without undue interference from the state.  The state, however, she argues, 
may be justified in exercising some ‘influence’ over parental decision-
making through the practices of health professionals.  
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Box 1: Elements of informed choice for newborn screening:
• Decisions are made voluntarily;
• by parents who have considered and understood information about 
the screening,12 including the benefits and risks;4
• in line with their own values,18 beliefs, wishes or priorities;20 
• to accept or decline screening for all or some of the conditions;
• to accept or decline tests that identify carrier status;
• to accept or decline follow-up screening or diagnostic tests;
• to accept or decline receiving invitations to participate in research 
related to the newborn blood spot screening programme.
• The extent of parent choice to be offered with regard to the use of 
DNA analysis as part of screening, and the use of residual blood 
spots for wider public health purposes and research remain limited.
Box 2: Context of informed choice for newborn blood spot screening
Approximately 600,000 babies each year, tested for serious but rare 
conditions:
• Eleven babies in every 100,000 births will have phenylketonuria 
(PKU),21 a condition which affects the processing of a protein called 
phenylalanine, that, unless treated, can lead to serious 
developmental problems and mental disability by the time the child 
is six months old.  
• One in approximately every 4,000 babies in the UK will have 
congenital hypothyroidism (CHT),22 caused by a malfunctioning or 
missing thyroid gland.  Babies with CHT lack the hormone 
thyroxine, needed for normal growth and development, and can 
become severely mentally impaired.  
• One in every 2,500 babies has cystic fibrosis (CF),23 a condition that 
affects the lungs and digestive systems, leading to chronic illness.
• One in 2,380 babies in the UK is born with a sickle cell disorder 
(SCD),24 which causes the red blood cells to change to a crescent 
shape and become stuck in small blood vessels, causing pain, tissue 
damage and infection that can be fatal.  
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Table 1: Study participants
Participants Data collection methods
19 parents of unaffected babies 3 focus groups;* 1 telephone 
interview
6 parents of babies with PKU 1 focus group; 4 interviews
10 parents of babies with congenital 
hypothyroidism
interviews
6 parents of babies with sickle cell 
disorders
1 focus group
6 parents of babies with cystic 
fibrosis
interviews**
6 midwives interviews
4 health visitors interviews
4 cystic fibrosis nurses interviews
8 sickle cell counsellors/ specialist 
nurses
interviews
6 paediatricians interviews
7 general practitioners interviews
*  One mother was also a midwife and participated in a focus group 
primarily as a parent, but commented briefly on her views as a health 
professional. Another mother was formerly a midwife and commented in a 
focus group on her previous experiences as a midwife.
** One parent was also a GP and was interviewed separately as a parent and 
as a health professional.
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Fig. 1: Elements of decisions for newborn bloodspot screening
Degree of parental choice
Screening compulsory Screening routine: opt out possible Screening a choice
Information for parents
Minimal / oral / one way communication                                        Complete / oral and written / discussed
Recognition of parental decision
Consent assumed Consent implied Oral consent Consent / dissent 
recorded
Consent / dissent 
signed
Parental choice and responsibility
Increasing choice and responsibility is
supported (by improved quality of information and communication) 
AND/OR
imposed (by recorded or signed written consent / dissent) 
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